| Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis A Dimou, KN Syrigos, MW Saif World journal of gastroenterology: WJG 15 (30), 3734, 2009 | 150 | 2009 |
| Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO-1 predicts improved outcomes of anti–PD-1 therapies in metastatic melanoma DB Johnson, J Bordeaux, JY Kim, C Vaupel, DL Rimm, TH Ho, ... Clinical Cancer Research 24 (21), 5250-5260, 2018 | 138 | 2018 |
| Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer. F Skoulidis, KC Arbour, MD Hellmann, PD Patil, ME Marmarelis, ... Journal of Clinical Oncology 37 (15_suppl), 102-102, 2019 | 104 | 2019 |
| Predictive value of oncogenic driver subtype, programmed death‐1 ligand (PD‐L1) score, and smoking status on the efficacy of PD‐1/PD‐L1 inhibitors in patients with oncogene … TL Ng, Y Liu, A Dimou, T Patil, DL Aisner, Z Dong, T Jiang, C Su, C Wu, ... Cancer 125 (7), 1038-1049, 2019 | 77 | 2019 |
| Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer A Dimou, KN Syrigos, MW Saif Therapeutic advances in medical oncology 4 (5), 271-279, 2012 | 74 | 2012 |
| ROS1 gene rearrangements are associated with an elevated risk of peridiagnosis thromboembolic events TL Ng, DE Smith, R Mushtaq, T Patil, A Dimou, S Yang, Q Liu, X Li, ... Journal of Thoracic Oncology 14 (4), 596-605, 2019 | 64 | 2019 |
| MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis A Dimou, L Non, YK Chae, WJ Tester, KN Syrigos PloS one 9 (9), e107677, 2014 | 64 | 2014 |
| CT pulmonary angiography utilization in the emergency department: diagnostic yield and adherence to current guidelines A Perelas, A Dimou, A Saenz, JH Rhee, K Teerapuncharoen, A Rowden, ... American Journal of Medical Quality 30 (6), 571-577, 2015 | 50 | 2015 |
| Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancer A Dimou, V Neumeister, S Agarwal, V Anagnostou, K Syrigos, DL Rimm The American journal of pathology 181 (4), 1436-1442, 2012 | 47 | 2012 |
| Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype T Rampias, E Pectasides, M Prasad, C Sasaki, P Gouveris, A Dimou, ... Annals of oncology 24 (8), 2124-2131, 2013 | 39 | 2013 |
| Incidental findings on computed tomography angiography in patients evaluated for pulmonary embolism A Perelas, A Dimou, A Saenz, JH Rhee, K Teerapuncharoen, A Rowden, ... Annals of the American Thoracic Society 12 (5), 689-695, 2015 | 38 | 2015 |
| Neuroendocrine tumors of the pancreas: what's new AT Dimou, KN Syrigos, MW Saif JOP. Journal of the Pancreas 11 (2), 135-138, 2010 | 34 | 2010 |
| Molecular classification of nonsmall cell lung cancer using a 4‐protein quantitative assay VK Anagnostou, AT Dimou, T Botsis, EJ Killiam, MD Gustavson, ... Cancer 118 (6), 1607-1618, 2012 | 29 | 2012 |
| Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non–small cell lung … A Dimou, S Agarwal, V Anagnostou, H Viray, S Christensen, BG Rothberg, ... The American journal of pathology 179 (2), 580-589, 2011 | 26 | 2011 |
| The effect of calcium channel blockers on the outcome of acute myeloid leukemia YK Chae, A Dimou, S Pierce, H Kantarjian, M Andreeff Leukemia & lymphoma 55 (12), 2822-2829, 2014 | 23 | 2014 |
| Non-small cell lung cancer beyond biomarkers: The evolving landscape of clinical trial design A Dimou, V Papadimitrakopoulou Journal of Personalized Medicine 4 (3), 386-401, 2014 | 22 | 2014 |
| Inhibition of renin angiotensin axis may be associated with reduced risk of developing venous thromboembolism in patients with atherosclerotic disease YK Chae, D Khemasuwan, A Dimou, S Neagu, L Chebrolu, S Gupta, ... PLoS One 9 (1), e87813, 2014 | 22 | 2014 |
| From the bench to bedside: biological and methodology considerations for the future of companion diagnostics in nonsmall cell lung cancer A Dimou, K Harrington, KN Syrigos Pathology research international 2011, 2011 | 22 | 2011 |
| Is there a role for mitomycin C in metastatic colorectal cancer? A Dimou, KN Syrigos, MW Saif Expert opinion on investigational drugs 19 (6), 723-735, 2010 | 21 | 2010 |
| Rationale for inhibition of the hedgehog pathway paracrine loop in pancreatic adenocarcinoma A Dimou, K Syrigos, MW Saif JOP. Journal of the Pancreas 12 (1), 1-5, 2011 | 18 | 2011 |
David RimmYale UniversityVerified email at yale.edu
